These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4891544)

  • 1. [Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test"].
    Buraczewska M; Chodkowska S; Paklerska-Pobratyn H
    Gruzlica; 1969 Feb; 37(2):93-9. PubMed ID: 4891544
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test".
    Buraczewska M; Chodkowska S; Paklerska-Pobratyn H
    Pol Med J; 1969; 8(5):1136-42. PubMed ID: 4245977
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies of 5 BCG substranins. I. Residual virulence of the French, Soviet, Swedish, Japanese and Rumanian substrains.
    Gheorghiu M; Paraschiveso M; Petrovici-Venson E
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):531-9. PubMed ID: 4923821
    [No Abstract]   [Full Text] [Related]  

  • 4. [Variability of the BCG Moreau substrain. II. Comparison of the allergizing and protective properties of BCG substrains of various origins].
    Janaszek W
    Med Dosw Mikrobiol; 1983; 35(2):97-105. PubMed ID: 6369043
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative laboratory evaluation of the protective properties of French and Braziliam BCG substrains and of vaccines produced from these strains in Poland].
    Szulkin E
    Med Dosw Mikrobiol; 1966; 18(4):345-52. PubMed ID: 5334256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative studies on the French and Brazilian BCG substrains and lyophilized vaccines].
    Buraczewska M; Chodkowska S; Janowiec M; Kostrzeński W; Manowska W; Paklerska-Pobratyn H; Pichula K; Tuszyńska-Pelczarska B
    Gruzlica; 1966 Jun; 34(6):513-24. PubMed ID: 5336366
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sensitivity of the protection test in guinea pigs vaccinated by BCG. I. Influence of age or slight viability margins of BCG cultures].
    Frappier A; Portelance V; Marois P; St-Pierre J
    Ann Inst Pasteur (Paris); 1967 Sep; 113(3):425-47. PubMed ID: 4860409
    [No Abstract]   [Full Text] [Related]  

  • 8. [Variability of the BCG Moreau substrain. I. Comparison of morphology and residual virulence of BCG substrains of various origins].
    Janaszek W
    Med Dosw Mikrobiol; 1983; 35(2):85-95. PubMed ID: 6369042
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of the study of the W 115 M. tuberculosis vaccine strain and the lyophilized experimental vaccine W 115.
    Weiszfeiler JG
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):492-7. PubMed ID: 812909
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study of the biological activity of BCG substrains].
    Rozenberg AM
    Probl Tuberk; 1971; 49(6):80-5. PubMed ID: 4940643
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative studies of 5 G substrains. II. Tuberculin sensitization with 5 BCG vaccines].
    Paraschivesco M; Gheorghiu M; Petrovici-Venson E
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):541-4. PubMed ID: 4923822
    [No Abstract]   [Full Text] [Related]  

  • 12. [Laboratory studies on the Russian BCG vaccine and comparison with th Polish vaccine prepared from the Brazilian substrain].
    Buraczewska M; Paklerska-Pobratyn H; Pichula K
    Gruzlica; 1967 Jul; 35(7):609-18. PubMed ID: 6078562
    [No Abstract]   [Full Text] [Related]  

  • 13. [Virulence of BCG and induction of cellular immunity (2)].
    Miura K; Takahashi H; Murohashi T; Hashimoto T
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):255. PubMed ID: 765561
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the in vivo multiplication of 10 BCG substrains in three strains of mice: no correlation with their antitumour activity.
    Frenette M; Portelance V; Beaudet R
    Microbios; 1983; 36(145-46):173-82. PubMed ID: 6346021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety.
    Chen JM; Islam ST; Ren H; Liu J
    Vaccine; 2007 Nov; 25(48):8114-22. PubMed ID: 17954004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic acid production of BCG substrains in relationship to their residual virulence and immunogenic efficacy.
    Zureck A
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):436-43. PubMed ID: 812905
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute BCG-infection].
    Muftic M
    Beitr Klin Erforsch Tuberk Lungenkr; 1967; 135(5):370-6. PubMed ID: 4876570
    [No Abstract]   [Full Text] [Related]  

  • 18. [Residual virulence of lyophilized commercial BCG-Brazil vaccine, and of the one cultured in Dubos media for mice].
    Fonseca Lde S; Gontijo Filho PP
    An Microbiol (Rio J); 1979; 24():182-9. PubMed ID: 400665
    [No Abstract]   [Full Text] [Related]  

  • 19. [BCG: substrains, the vaccine, vaccination].
    Balazs ED
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(3):117-24. PubMed ID: 9417279
    [No Abstract]   [Full Text] [Related]  

  • 20. The virulence of some strains of BCG for golden hamsters.
    Bunch-Christensen K; Ladefoged A; Guld J
    Bull World Health Organ; 1968; 39(5):821-8. PubMed ID: 4893582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.